Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Nicotine Therapy for Smoking Cessation in Syria
NCT01085032Phase 2Completed
- Sponsor
- University of Memphis
- Start
- Aug 2006
- Primary completion
- Jul 2009
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing Behavioral Counseling + Nicotine Patch with Behavioral Counseling + Placebo Patch (2 arms). Primary endpoint: Prolonged Abstinence at 12 months. Started Aug 2006; status: completed.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01085032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01085032.